PROTOKINETIX BLOG

Find out how AAGP® is changing lives through cell survival

As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.

Jun 05, 2017

byprotokinetix92b

Biomanufacturing

ProtoKinetix and Proactive Immune Sciences Announce a Joint Research Collaboration Using AAGP® in Immune Cell Cryopreservation Testing

St. Marys, West Virginia ProtoKinetix, Incorporated (PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) and Proactive Immune Sciences (www.proactiveimmunesciences.com) today announce that they have entered into a joint research collaboration. The goal of...Read more

Jun 07, 2016

byprotokinetix92b

Biomanufacturing | Ophthalmology | Transplants

ProtoKinetix’ AAGP® has been Published in the Journal of Tissue Engineering and Regenerative Medicine

St. Marys, West Virginia ProtoKinetix, Incorporated (OTCQB:PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix’ AAGP® has been published...Read more

Request More Information

Talk to a member of the ProtoKinetix team to learn more about our research and results.